Identification of Anti‐Mycobacterial Biofilm Agents Based on the 2‐Aminoimidazole Scaffold
- 4 March 2019
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 14 (9) , 927-937
Abstract
Tuberculosis (TB) remains a significant global health problem for which new therapeutic options are sorely needed. The ability of the causative agent, Mycobacterium tuberculosis, to reside within host macrophages and form biofilm‐like communities contributes to the persistent and drug‐tolerant nature of the disease. Compounds that can prevent or reverse the biofilm‐like phenotype have the potential to serve alongside TB antibiotics to overcome this tolerance, and decrease treatment duration. Using Mycobacterium smegmatis as a surrogate organism, we report the identification of two new 2‐aminoimidazole compounds that inhibit and disperse mycobacterial biofilms, work synergistically with isoniazid and rifampicin to eradicate preformed M. smegmatis biofilms in vitro, are nontoxic toward Galleria mellonella, and exhibit stability in mouse plasma.Keywords
Funding Information
- National Institutes of Health (AI106733)
This publication has 25 references indexed in Scilit:
- Reversal ofMycobacterium tuberculosisphenotypic drug resistance by 2-aminoimidazole-based small moleculesPathogens and Disease, 2014
- Small Molecule Downregulation of PmrAB Reverses Lipid A Modification and Breaks Colistin ResistanceACS Chemical Biology, 2013
- Targeting drug tolerance in mycobacteria: a perspective from mycobacterial biofilmsExpert Review of Anti-infective Therapy, 2012
- Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput ScreeningACS Chemical Biology, 2012
- Growth of Mycobacterium tuberculosis BiofilmsJournal of Visualized Experiments, 2012
- Small Molecule Suppression of Carbapenem Resistance in NDM-1 Producing Klebsiella pneumoniaeACS Medicinal Chemistry Letters, 2012
- The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumanniiBioorganic & Medicinal Chemistry, 2010
- Chemotherapy and diagnosis of tuberculosisRespiratory Medicine, 2006
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- Directly observed therapy for tuberculosis: history of an ideaThe Lancet, 1995